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with known premature CHD IS important and may influence subsequent risk 
of early CHD in asymptomalJc family members. 
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-97 Ten Year Trends in Cam for Congestive Hospital 
Neart Failure: Improved Cu:comes. Increased 
Procedures and Higher Costs 
C.A. Polanczyk~ LE.P. Ro~de. M. CaiL T. DiSaNo. Massac/~etm Genera/ 
Hos, o~ak Bos~o,. MA. USA 
Chazcje~ o~er ttme in outcomes and resource u~l~zabon m ~ta l  care O1 
congestive heart failure (CHF) have no1 been widely stuched. To exan~ne 
tre~ls of mortality rates, resource utdizatJon and cosls in pabents edmittsd to 
an academic medical center, all 6,676 pahents hospitalized with pnman/ICD-9 
c~ag~:~ses of CHF between 1986 apd 1996 were ~ .  Palmer outcomes 
and resource utilizal~n were ~Lsk-adjusted for ~ i c  charac- 
tenstics and asso~aled comod~ties using muffiple regression analyses. A 
yearly, discount rate ol 7% was used 1o convert all costs to 1996 US~. 
Resu/ts (see table): The mean age was 70 + 13 years. 54% were male 
and 87% were white. FOr all trends, p value <0.01. Invas=ve prooedures = 
cardiac catheterization, PTCA. CABG, IABP, mechamcat ventilation, invas=ve 
hemedynamic monitoring and dialysis. 
Conclus~n: A significant decrease in hospital mortality was obsewed in 
a 10 year period, even after controlling for soc,o-demographic haracteristics 
Yearn 1986-87 1988--89 1990-91 1992-93 1994~96 
(n=942) (n=1126) (n=1302) (n=1411) (n=1896) 
ln-hospi~l mortals'y, % 8.4 8.5 7.1 6.3 6.1 
Ad~sted motla|~tv 9.1 8.8 6.7 5.7 6.4 
Invasive Procedures. % 19 21 24 28 24 
Length of stay. days 9.6 10.7 11.2 10.3 8.8 
Adjusted length of ~ay 104 11.0 10.9 9.9 8.9 
Total costs, 1996 US$ 2,814 4,182 7.036 10,760 12,759 
Adjusted total costs 2,800 4.107 6.913 10,579 13.039 
arx:l comod),dfflo8, Those data indcata that the decreM4) m mortallly was 
achmved at the aXlpenso o! increased procedure ulihzaho~ sad h~gher Overall 
hesp~tal co6ta, 
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JA. Wal(k~, M,A, Hell,lion, G,C. FoNifow, MJ~. Woo, NA I.Mngs1On, 
^, Hage, JD, Moftg~hi, UC/,A Me¢~ Cent,, to~ Ange~ CA, 
v~n¢~ hemt faikn~, we ~ BS3 ~ who were evaJuatad and ac- 
to~ bean ~n~pkmtaUon (l"x) t~tween lm2 and l~uge,/Ul pmmm 
were ~ at a ~nlm~m of ~ 2-3 monl~ m l~e l~an lai!wo ¢emer, t~t 
r, on-HMO pm had ¢imat~ ~ to ~ ~m.  Pmmm w~e ~ 
ba,~ed on the~¢ I ~  ~ ins~n, ece ¢overeoe ~ ana~ ¢o¢ 
~ at brae el mlewal, peR~ tr~nslp~lllecL ,=tat~m attime of Tx, 4m¢1 sur- 
vWal. In ~ four If~urance calt~gofi~, 168 (34%) pt~ had p~vale insurance 
(P), 123 (22%) ha~ managed ¢~re plans (HMO), 148 (aS%) hed MedC, me 
(MCfl), and t 04 (I 6%) had MedcaKI (MCD). A. 4 gn~pe had stricter 
el ilMe~s ~ at lime O! ~mral (mean ~ 52 y~. NYHA 35, LVEF 24). 
W~th average f/u of 19 mont~, no difference, were ~ m fotal modal~. 
Howe~. a g~er  pmpe~ of HMO pts ~md u~0e~ 1"I (20%), con~ 
pared Io P, MCR, and MCD (15%, 1~,  19% p < O.0C01, p = 0.02, p = 0.18) 
Addemmdly, fe~me HMO pts were able to ewo~ Tx (44%), compam~ fo P and 
MCD (5~%, 61% p = 0.04, p =, 0.0~). 
Cm~eumo~- ~ ovem~ mmm,,al was ~mitar aoo~ all mmeance 
groups, patieofs caverecl ~ ~ cam I~ns mqu=~l urgem heart 
uan=plama~on ~ f~lUe~ and ~e~e les~ likely ~ ave¢l ~ .  
~ access ~ a hea~ lm]um specudNy centre may help to maxn~,ze 
c~ca~ mb~y a~ anew pa~e~ to de~ ,ansp~a~o~ v~out adveme~ 
effec~g sun~al. 
~ Ide~l~in 9 Patients Risk for Recurrent at Hospnal 
Admission for Heart Failure 
EF ~ J.B. I :ke fden. / - i~ Fotz/Ho~0~a/. Deh~L Aft& Ba~mett 
Hea~ca~e. C~,s lown.  N~. USA 
Ba~mpta~- Recurrent hospital adm~s~on~ for HF are &arrmngty common; 
Me,Jxx~: Usmcj b,~e New Yo~ sla~,;,~ hc,-~mial data set we compamcl the 
bet,~men 9,112 palm~ts ~ only 1 HF acb~s~io~ and 33,619 w~ll 
>1 during 1995: ~ .  ~ illness, hos~tal l ype / Io (~ L~Xt 
processes of care. A simple readm~ss~ort Risk Score was denved by count- 
=p.g Itte number of pesdwe pred~ors present minus the number ot neg,ztwa 
predictors 
Results: Reg=b~ss,on was independontty related to I~k  inca. ~ i d  
a~d MedCare msuranoe, ~;;-,,~ ~=ptal, tek~e~ monit~ng, disc~rge 
against advK:e, and these ~ :  molemic and valvular head dis- 
ease. k.~,,~tttic caraiomyopalhy. ~ i~.  renal disease, COPD, ~ heart 
surgmy, benpl~eral vascular disease and anem~. Di~pdaarge to a numing 
home. carc~ac ath and ~ were retat~ 1o k.'wer isk. ~ 
~s the incremental mlabonsh,p between Rink Score and read , l t t~ rate: 
Score Rate Score Rate Score Rate 
3 to 0 9 6",, 3 20.0% 6 29.7% 
1 13.6% 4 23.1% 7 34 ~,~ 
2 166% 5 263% ;8 400% 
Conc~usiorts: 11 Using a large, co.-nl~rehensNe data set not restrcted by 
insurance payor, we identttied s~gnificant preo%~ors O1 recurrent aoYnffiston for 
HF: 2) our simple Risk Score fright be used to ,dentify candidates for care 
management o reduce readmissions 
~ W n a t  Matters to Patients With Severe Heart Really 
Failure: Tradeoffs Between Quantity and Qua l i~  
of Life 
K.D. Aaronson. J HoaShi, J. Bowers. T.-M. Chen. UnwersttyofM~h~gan 
Medical Center, Ann Arbor. ML USA 
Background: Although development and approval of drugs for CHF is largely 
focused on improving sun~ival, a drug's impact on quantity of life may differ 
from its effect on quality of life (QOL). How patients (pts) w~h severe CHF 
value quantity vs. QOL is unknown. 
Methods: We assessed the willingness of outpatients with chronic NYHA 
class III (n = 44) or IV (n = 3) CHF to accept decreased (~uant~ty to obtain im- 
proved QOI_ QOL was assessed with the Living with Heart Failure Question- 
naire (LHFQ). Utility for CHF-related QOL w~s assessed ~' st=_ndard gamble 
